A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2014
This article has no abstract
Epistemonikos ID: 7e5327f7a690ad2e34d1f6b858aea0483e150591
First added on: Feb 06, 2025